AHLA Publishes Health Care Transactions Manual: Understanding the Consequences of the Health Care Deal
- May 06, 2020
Published by the American Health Law Association, the Health Care Transactions Manual: Understanding the Consequences of the Health Care Deal is the ideal guide for gaining an understanding of the legal landscape, and for managing the risks involved in structuring health care deals.
Health care transactions pose unique and complex legal questions arising from intense federal and state regulation and enforcement. Further, what makes sense in the business world does not always make sense in the health care world. Readers will gain critical insight into nuances such as:
- When seemingly straightforward business terms can veer toward health care fraud and abuse
- How health care organization and/or management structure can impact the deal
- The need to comply with both non-disclosure terms and federal and state privacy laws when conducting due diligence
- How increased collaboration between health care entities may give raise to antitrust issues
- How tax-exempt status may be impacted in the course of a deal between exempt and non-exempt entities
- State and federal environmental implications as they relate to radioactive materials used in patient care, for example
- And much more
“This Manual covers everything from transactional basics to deep dive discussions for negotiating complicated deals,” comments Robert Anderson, AHLA’s Senior Director of Publishing. “Because AHLA authors and members are practicing attorneys, we were able to include more than 20 valuable time saving tools and exhibits, ranging from sample due diligence requests to a closing checklist.”
Health Care Transactions Manual: Understanding the Consequences of the Health Care Deal is available to order through AHLA’s store on the LexisNexis website for both members of AHLA and the broader health law professionals community.
For a high-resolution image of the book cover, editor/author headshots, or interview inquiries, please contact AHLA.